{"id":2822,"date":"2021-03-17T03:24:59","date_gmt":"2021-03-17T03:24:59","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2822"},"modified":"2023-08-29T18:01:51","modified_gmt":"2023-08-29T18:01:51","slug":"creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2822","title":{"rendered":"Creso Pharma\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c"},"content":{"rendered":"<p>\u8fd1\u65e5\uff0c<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=CPH&amp;lang=cn\">Creso Pharma (ASX: CPH)<\/a>\u5ba3\u5e03\u4e86\u6536\u8d2d\u52a0\u62ff\u5927\u8ff7\u5e7b\u836f\u516c\u53f8Halucenex\u7684\u8ba1\u5212\uff0c\u5e76\u5ba3\u5e03\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8d1f\u8d23\u5176\u76ee\u6807\u516c\u53f8\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>Creso\u672c\u5468\u65e9\u4e9b\u65f6\u5019<a href=\"http:\/\/smallcaps-production.test\/creso-pharma-acquire-canadian-psychedelics-company-halucenex\/?lang=cn\">\u5ba3\u5e03\u6709\u610f\u6536\u8d2dHalucenex Life Sciences Inc<\/a> \uff0c\u6b64\u4e3e\u5c06\u4f7f\u5176\u6210\u4e3a\u4e00\u4e2a\u591a\u5143\u5316\u7684\u5929\u7136\u836f\u7269\u4e1a\u52a1\uff0c\u5e76\u4f7f\u5176\u5728\u8ff7\u5e7b\u836f\u9886\u57df\u62e5\u6709\u5148\u673a\u4f18\u52bf\u3002<\/p>\n<p>\u4e13\u6ce8\u4e8e\u5f00\u53d1\u65b0\u578b\u8ff7\u5e7b\u836f\u7684Halucenex\u6b63\u81f4\u529b\u4e8e\u542f\u52a8\u7b2c\u4e8c\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u6d4b\u8bd5\u88f8\u76d6\u83c7\u7d20(\u795e\u5947\u8611\u83c7\u4e2d\u7684\u6d3b\u6027\u6210\u5206)\u5bf9\u9000\u4f0d\u519b\u4eba\u548c\u6025\u6551\u4eba\u5458\u6297\u6cbb\u7597\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u7597\u6548\u3002<\/p>\n<p>\u5728\u4eca\u5929\u7684\u66f4\u65b0\u4e2d\uff0cCreso\u901a\u77e5Halucenex\u5df2\u7ecf\u4efb\u547dTrue North Clinical Research\u4e3a\u8be5\u8bd5\u9a8c\u7684\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u9884\u8ba1\u5c06\u4e8e6\u6708\u5f00\u59cb\uff0c\u5e76\u5f97\u5230\u52a0\u62ff\u5927\u536b\u751f\u90e8\u7684\u6279\u51c6\u3002<\/p>\n<p>\u636eCreso\u4ecb\u7ecd\uff0cTrue North\u662f\u4e00\u5bb6\u9886\u5148\u7684\u7814\u53d1\u96c6\u56e2\uff0c\u201c\u4e0e\u52a0\u62ff\u5927\u6b66\u88c5\u90e8\u961f\u548c\u9000\u4f0d\u519b\u4eba\u6709\u7740\u7262\u56fa\u7684\u8054\u7cfb\uff0c\u8fd9\u5bf9\u8bd5\u9a8c\u6765\u8bf4\u662f\u5fc5\u4e0d\u53ef\u5c11\u7684\u201d\u3002\u7279\u522b\u8981\u63d0\u7684\u662f\uff0c\u8be5\u7ec4\u7ec7\u7684\u521b\u59cb\u4eba\u517c\u9996\u5e2d\u6267\u884c\u5b98Mark Johnston\u535a\u58eb\u572820\u5e74\u7684\u7cbe\u795e\u79d1\u533b\u751f\u751f\u6daf\u4e2d\uff0c\u66fe\u5728\u591a\u4e2a\u519b\u4e8b\u7ec4\u7ec7\u5de5\u4f5c\u8fc7\u3002<\/p>\n<p>Mark Johnston\u535a\u58eb\u8bf4\uff0cHalucenex\u5bf9\u8fdb\u884c\u8fd9\u9879\u53ef\u80fd\u5177\u6709\u5f00\u521b\u6027\u7684\u7814\u7a76\u611f\u5230\u5174\u594b\uff0c\u56e0\u4e3a\u201c\u5c3d\u7ba1\u5168\u4e16\u754c\u6709100\u591a\u4e07\u9000\u4f0d\u519b\u4eba\u88ab\u8bca\u65ad\u60a3\u6709\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\uff0c\u4f46\u6709\u6548\u7684\u836f\u7269\u6cbb\u7597\u4e25\u91cd\u7f3a\u4e4f\u3002\u201d<\/p>\n<p>Halucenex\u521b\u59cb\u4eba\u517c\u9996\u5e2d\u6267\u884c\u5b98Bill Fleming\u8865\u5145\u8bf4\uff0c\u8be5\u8bd5\u9a8c\u5c06\u4f7f\u4e24\u5bb6\u516c\u53f8\u5c06\u4ed6\u4eec\u7684\u4e34\u5e8a\u8bd5\u9a8c\u548c\u5fc3\u7406\u5b66\u4e13\u4e1a\u77e5\u8bc6\u7ed3\u5408\u5728\u4e00\u8d77\uff0c\u201c\u4e3a\u5f53\u524d\u548c\u672a\u6765\u7684\u60a3\u8005\u5e26\u6765\u6700\u5927\u7684\u5229\u76ca\u201d\u3002<\/p>\n<p>\u4ed6\u8bf4:\u201c\u6211\u4eec\u671f\u5f85\u4e0eTrue North\u5efa\u7acb\u957f\u671f\u3001\u5bcc\u6709\u6210\u6548\u548c\u6210\u529f\u7684\u5173\u7cfb\u3002\u201d<\/p>\n<p>\u201c\u9000\u4f0d\u519b\u4eba\u548c\u6025\u6551\u4eba\u5458\u6bcf\u5929\u90fd\u4e3a\u793e\u4f1a\u4ed8\u51fa\u4e86\u8fd9\u4e48\u591a\uff0c\u6211\u4eec\u6b20\u4ed6\u4eec\u7684\u662f\u627e\u5230\u6700\u6709\u6548\u7684\u6cbb\u7597\u65b9\u6cd5\u3002\u8fd9\u6b21\u5ba1\u5224\u662f\u671d\u7740\u6b63\u786e\u65b9\u5411\u8fc8\u51fa\u7684\u4e00\u5927\u6b65\u3002\u201d<\/p>\n<p>\u4f5c\u4e3a\u9996\u5e2d\u7814\u7a76\u5458\uff0cTrue North\u5c06\u4e3a\u8bd5\u9a8c\u63d0\u4f9b\u4e34\u5e8a\u76d1\u7763\uff0c\u534f\u52a9\u4fc3\u8fdb\u65b0\u65af\u79d1\u820d\u7701\u4f26\u7406\u59d4\u5458\u4f1a\u7684\u4f9d\u4ece\u6027\uff0c\u627f\u62c5\u60a3\u8005\u62db\u52df\u8ba1\u5212\uff0c\u8fdb\u884c\u8bd5\u9a8c\uff0c\u76d1\u6d4b\uff0c\u6570\u636e\u91c7\u96c6\u548c\u7ed3\u679c\u6c47\u7f16\uff0c\u5e76\u786e\u4fdd\u540e\u7eed\u63aa\u65bd\u7684\u91c7\u53d6\uff0c\u4ee5\u786e\u4fdd\u53c2\u4e0e\u8005\u7684\u5b89\u5168\u3002<\/p>\n<h2>\u7b2c\u4e8c\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c<\/h2>\n<p>\u8fd9\u9879\u62df\u8fdb\u884c\u7684\u8bd5\u9a8c\u662f\u7b2c\u4e8c\u9636\u6bb5\uff0c\u5355\u81c2\uff0c\u5f00\u653e\u6807\u7b7e\u8bd5\u9a8c\uff0c\u4ee5\u786e\u5b9a\u88f8\u76d6\u83c7\u7d20\u5728\u6cbb\u7597\u96be\u6cbb\u6027PTSD\u60a3\u8005\u4e2d\u7684\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u3002\u8be5\u8bd5\u9a8c\u8fd8\u5c06\u6700\u7ec8\u786e\u5b9a\u88f8\u76d6\u83c7\u7d20\u5728\u8be5\u9002\u5e94\u75c7\u7684\u672a\u6765\u8bd5\u9a8c\u7684\u53ef\u884c\u6027\u3002<\/p>\n<p>Halucenex\u9884\u8ba1\u62db\u52df18 &#8211; 20\u540d\u60a3\u6709\u8fd9\u79cd\u75be\u75c5\u7684\u6210\u5e74\u4eba\uff0c\u5e76\u57287\u5929\u5185\u5206\u522b\u4f7f\u7528\u4e24\u79cd\u5242\u91cf\u7684\u88f8\u76d6\u83c7\u7d20\u8fdb\u884c\u6cbb\u7597:\u7b2c7\u5929\u4f7f\u752810mg\u7684\u5fae\u91cf\u5242\u91cf\uff0c\u7b2c14\u5929\u4f7f\u752825mg\u7684\u5927\u5242\u91cf\u3002<\/p>\n<p>\u5728\u81f4\u5e7b\u671f\uff0c\u7814\u7a76\u76d1\u6d4b\u5668\u5c06\u5728\u8bca\u6240\u5bc6\u5207\u76d1\u6d4b\u60a3\u8005\uff0c\u5e76\u8fdb\u884c\u5b89\u5168\u8bc4\u4f30\uff0c\u5305\u62ec\u4e0d\u826f\u53cd\u5e94\u548c\u751f\u547d\u4f53\u5f81\u7684\u4e8b\u4ef6\u3002<\/p>\n<p>\u5728\u7ed9\u836f\u540e6\u52307\u5c0f\u65f6\uff0c\u60a3\u8005\u5c06\u4e3b\u89c2\u5730\u8bc4\u4ef7\u88f8\u76d6\u83c7\u7d20\u7684\u4f5c\u7528\u5f3a\u5ea6\u3002\u4ed6\u4eec\u8fd8\u5c06\u88ab\u8981\u6c42\u5728\u6cbb\u7597\u540e\u7684\u51e0\u5929\u56de\u5230\u8bca\u6240\u8fdb\u884c\u7597\u6548\u548c\u5b89\u5168\u6027\u8bc4\u4f30\u3002<\/p>\n<p>\u60a3\u8005\u8bc6\u522b\u6807\u51c6\u5df2\u7ecf\u5f00\u59cb\uff0c\u8bd5\u9a8c\u8ba1\u5212\u4e8e6\u6708\u5f00\u59cb\uff0c\u4f46\u5fc5\u987b\u83b7\u5f97\u52a0\u62ff\u5927\u536b\u751f\u90e8\u7684\u4e34\u5e8a\u8bd5\u9a8c\u6388\u6743\u8bb8\u53ef\u3002\u83b7\u5f97\u8fd9\u4e00\u8bb8\u53ef\u8bc1\u6240\u9700\u7684\u6587\u4ef6\u9884\u8ba1\u5c06\u4e8e\u56db\u6708\u5e95\u63d0\u4ea4\u3002<\/p>\n<h2>Halucenex\u8001\u677f\u88ab\u6536\u8d2d\u540e\u5c06\u63a5\u66ffCreso\u8463\u4e8b<\/h2>\n<p>Creso\u8fd8\u5efa\u8baeFleming\u5148\u751f\u5728\u6536\u8d2d\u5b8c\u6210\u540e\u63a5\u66ffMiri Halperin Wernli\u535a\u58eb\u62c5\u4efbCreso\u7684\u8463\u4e8b\u3002<\/p>\n<p>Creso\u975e\u6267\u884c\u4e3b\u5e2dAdam Blumenthal\u5728\u4eca\u5929\u7684\u58f0\u660e\u4e2d\u611f\u8c22Halperin Wernli\u535a\u58eb\u5bf9Creso\u7684\u627f\u8bfa\u3002<\/p>\n<p>\u4ed6\u8bf4:\u201c\u5728\u5979\u4efb\u804c\u671f\u95f4\uff0c\u5979\u5728Creso Pharma\u7684\u6210\u529f\u4e2d\u53d1\u6325\u4e86\u5173\u952e\u4f5c\u7528\uff0c\u4e3a\u8463\u4e8b\u4f1a\u548c\u7ba1\u7406\u56e2\u961f\u5e26\u6765\u4e86\u5de8\u5927\u7684\u4ef7\u503c\uff0c\u5e76\u9886\u5bfc\u4e86\u4e00\u4e9b\u4e3e\u63aa\uff0c\u4e3a\u6211\u4eec\u7684\u80a1\u4e1c\u91ca\u653e\u4e86\u76f8\u5f53\u5927\u7684\u4ef7\u503c\u3002\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u8fd1\u65e5\uff0cCreso Pharma (ASX: CPH)\u5ba3\u5e03\u4e86\u6536\u8d2d\u52a0\u62ff\u5927\u8ff7\u5e7b\u836f\u516c\u53f8Halucenex\u7684\u8ba1\u5212\uff0c\u5e76\u5ba3\u5e03\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8d1f\u8d23\u5176\u76ee\u6807\u516c\u53f8\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002 Creso\u672c\u5468\u65e9\u4e9b\u65f6\u5019\u5ba3\u5e03\u6709\u610f\u6536\u8d2dHalucenex Life Sciences Inc \uff0c\u6b64\u4e3e\u5c06\u4f7f\u5176\u6210\u4e3a\u4e00\u4e2a\u591a\u5143\u5316\u7684\u5929\u7136\u836f\u7269\u4e1a\u52a1\uff0c\u5e76\u4f7f\u5176\u5728\u8ff7\u5e7b\u836f\u9886\u57df\u62e5\u6709\u5148\u673a\u4f18\u52bf\u3002 \u4e13\u6ce8\u4e8e\u5f00\u53d1\u65b0\u578b\u8ff7\u5e7b\u836f\u7684Halucenex\u6b63\u81f4\u529b\u4e8e\u542f\u52a8\u7b2c\u4e8c\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u6d4b\u8bd5\u88f8\u76d6\u83c7\u7d20(\u795e\u5947\u8611\u83c7\u4e2d\u7684\u6d3b\u6027\u6210\u5206)\u5bf9\u9000\u4f0d\u519b\u4eba\u548c\u6025\u6551\u4eba\u5458\u6297\u6cbb\u7597\u6027\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(PTSD)\u7684\u7597\u6548\u3002 \u5728\u4eca\u5929\u7684\u66f4\u65b0\u4e2d\uff0cCreso\u901a\u77e5Halucenex\u5df2\u7ecf\u4efb\u547dTrue North Clinical Research\u4e3a\u8be5\u8bd5\u9a8c\u7684\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u9884\u8ba1\u5c06\u4e8e6\u6708\u5f00\u59cb\uff0c\u5e76\u5f97\u5230\u52a0\u62ff\u5927\u536b\u751f\u90e8\u7684\u6279\u51c6\u3002 \u636eCreso\u4ecb\u7ecd\uff0cTrue North\u662f\u4e00\u5bb6\u9886\u5148\u7684\u7814\u53d1\u96c6\u56e2\uff0c\u201c\u4e0e\u52a0\u62ff\u5927\u6b66\u88c5\u90e8\u961f\u548c\u9000\u4f0d\u519b\u4eba\u6709\u7740\u7262\u56fa\u7684\u8054\u7cfb\uff0c\u8fd9\u5bf9\u8bd5\u9a8c\u6765\u8bf4\u662f\u5fc5\u4e0d\u53ef\u5c11\u7684\u201d\u3002\u7279\u522b\u8981\u63d0\u7684\u662f\uff0c\u8be5\u7ec4\u7ec7\u7684\u521b\u59cb\u4eba\u517c\u9996\u5e2d\u6267\u884c\u5b98Mark Johnston\u535a\u58eb\u572820\u5e74\u7684\u7cbe\u795e\u79d1\u533b\u751f\u751f\u6daf\u4e2d\uff0c\u66fe\u5728\u591a\u4e2a\u519b\u4e8b\u7ec4\u7ec7\u5de5\u4f5c\u8fc7\u3002 Mark Johnston\u535a\u58eb\u8bf4\uff0cHalucenex\u5bf9\u8fdb\u884c\u8fd9\u9879\u53ef\u80fd\u5177\u6709\u5f00\u521b\u6027\u7684\u7814\u7a76\u611f\u5230\u5174\u594b\uff0c\u56e0\u4e3a\u201c\u5c3d\u7ba1\u5168\u4e16\u754c\u6709100\u591a\u4e07\u9000\u4f0d\u519b\u4eba\u88ab\u8bca\u65ad\u60a3\u6709\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d\uff0c\u4f46\u6709\u6548\u7684\u836f\u7269\u6cbb\u7597\u4e25\u91cd\u7f3a\u4e4f\u3002\u201d Halucenex\u521b\u59cb\u4eba\u517c\u9996\u5e2d\u6267\u884c\u5b98Bill Fleming\u8865\u5145\u8bf4\uff0c\u8be5\u8bd5\u9a8c\u5c06\u4f7f\u4e24\u5bb6\u516c\u53f8\u5c06\u4ed6\u4eec\u7684\u4e34\u5e8a\u8bd5\u9a8c\u548c\u5fc3\u7406\u5b66\u4e13\u4e1a\u77e5\u8bc6\u7ed3\u5408\u5728\u4e00\u8d77\uff0c\u201c\u4e3a\u5f53\u524d\u548c\u672a\u6765\u7684\u60a3\u8005\u5e26\u6765\u6700\u5927\u7684\u5229\u76ca\u201d\u3002 \u4ed6\u8bf4:\u201c\u6211\u4eec\u671f\u5f85\u4e0eTrue North\u5efa\u7acb\u957f\u671f\u3001\u5bcc\u6709\u6210\u6548\u548c\u6210\u529f\u7684\u5173\u7cfb\u3002\u201d \u201c\u9000\u4f0d\u519b\u4eba\u548c\u6025\u6551\u4eba\u5458\u6bcf\u5929\u90fd\u4e3a\u793e\u4f1a\u4ed8\u51fa\u4e86\u8fd9\u4e48\u591a\uff0c\u6211\u4eec\u6b20\u4ed6\u4eec\u7684\u662f\u627e\u5230\u6700\u6709\u6548\u7684\u6cbb\u7597\u65b9\u6cd5\u3002\u8fd9\u6b21\u5ba1\u5224\u662f\u671d\u7740\u6b63\u786e\u65b9\u5411\u8fc8\u51fa\u7684\u4e00\u5927\u6b65\u3002\u201d \u4f5c\u4e3a\u9996\u5e2d\u7814\u7a76\u5458\uff0cTrue North\u5c06\u4e3a\u8bd5\u9a8c\u63d0\u4f9b\u4e34\u5e8a\u76d1\u7763\uff0c\u534f\u52a9\u4fc3\u8fdb\u65b0\u65af\u79d1\u820d\u7701\u4f26\u7406\u59d4\u5458\u4f1a\u7684\u4f9d\u4ece\u6027\uff0c\u627f\u62c5\u60a3\u8005\u62db\u52df\u8ba1\u5212\uff0c\u8fdb\u884c\u8bd5\u9a8c\uff0c\u76d1\u6d4b\uff0c\u6570\u636e\u91c7\u96c6\u548c\u7ed3\u679c\u6c47\u7f16\uff0c\u5e76\u786e\u4fdd\u540e\u7eed\u63aa\u65bd\u7684\u91c7\u53d6\uff0c\u4ee5\u786e\u4fdd\u53c2\u4e0e\u8005\u7684\u5b89\u5168\u3002 \u7b2c\u4e8c\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c \u8fd9\u9879\u62df\u8fdb\u884c\u7684\u8bd5\u9a8c\u662f\u7b2c\u4e8c\u9636\u6bb5\uff0c\u5355\u81c2\uff0c\u5f00\u653e\u6807\u7b7e\u8bd5\u9a8c\uff0c\u4ee5\u786e\u5b9a\u88f8\u76d6\u83c7\u7d20\u5728\u6cbb\u7597\u96be\u6cbb\u6027PTSD\u60a3\u8005\u4e2d\u7684\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u3002\u8be5\u8bd5\u9a8c\u8fd8\u5c06\u6700\u7ec8\u786e\u5b9a\u88f8\u76d6\u83c7\u7d20\u5728\u8be5\u9002\u5e94\u75c7\u7684\u672a\u6765\u8bd5\u9a8c\u7684\u53ef\u884c\u6027\u3002 Halucenex\u9884\u8ba1\u62db\u52df18 &#8211; 20\u540d\u60a3\u6709\u8fd9\u79cd\u75be\u75c5\u7684\u6210\u5e74\u4eba\uff0c\u5e76\u57287\u5929\u5185\u5206\u522b\u4f7f\u7528\u4e24\u79cd\u5242\u91cf\u7684\u88f8\u76d6\u83c7\u7d20\u8fdb\u884c\u6cbb\u7597:\u7b2c7\u5929\u4f7f\u752810mg\u7684\u5fae\u91cf\u5242\u91cf\uff0c\u7b2c14\u5929\u4f7f\u752825mg\u7684\u5927\u5242\u91cf\u3002 \u5728\u81f4\u5e7b\u671f\uff0c\u7814\u7a76\u76d1\u6d4b\u5668\u5c06\u5728\u8bca\u6240\u5bc6\u5207\u76d1\u6d4b\u60a3\u8005\uff0c\u5e76\u8fdb\u884c\u5b89\u5168\u8bc4\u4f30\uff0c\u5305\u62ec\u4e0d\u826f\u53cd\u5e94\u548c\u751f\u547d\u4f53\u5f81\u7684\u4e8b\u4ef6\u3002 \u5728\u7ed9\u836f\u540e6\u52307\u5c0f\u65f6\uff0c\u60a3\u8005\u5c06\u4e3b\u89c2\u5730\u8bc4\u4ef7\u88f8\u76d6\u83c7\u7d20\u7684\u4f5c\u7528\u5f3a\u5ea6\u3002\u4ed6\u4eec\u8fd8\u5c06\u88ab\u8981\u6c42\u5728\u6cbb\u7597\u540e\u7684\u51e0\u5929\u56de\u5230\u8bca\u6240\u8fdb\u884c\u7597\u6548\u548c\u5b89\u5168\u6027\u8bc4\u4f30\u3002 \u60a3\u8005\u8bc6\u522b\u6807\u51c6\u5df2\u7ecf\u5f00\u59cb\uff0c\u8bd5\u9a8c\u8ba1\u5212\u4e8e6\u6708\u5f00\u59cb\uff0c\u4f46\u5fc5\u987b\u83b7\u5f97\u52a0\u62ff\u5927\u536b\u751f\u90e8\u7684\u4e34\u5e8a\u8bd5\u9a8c\u6388\u6743\u8bb8\u53ef\u3002\u83b7\u5f97\u8fd9\u4e00\u8bb8\u53ef\u8bc1\u6240\u9700\u7684\u6587\u4ef6\u9884\u8ba1\u5c06\u4e8e\u56db\u6708\u5e95\u63d0\u4ea4\u3002 Halucenex\u8001\u677f\u88ab\u6536\u8d2d\u540e\u5c06\u63a5\u66ffCreso\u8463\u4e8b Creso\u8fd8\u5efa\u8baeFleming\u5148\u751f\u5728\u6536\u8d2d\u5b8c\u6210\u540e\u63a5\u66ffMiri Halperin Wernli\u535a\u58eb\u62c5\u4efbCreso\u7684\u8463\u4e8b\u3002 Creso\u975e\u6267\u884c\u4e3b\u5e2dAdam Blumenthal\u5728\u4eca\u5929\u7684\u58f0\u660e\u4e2d\u611f\u8c22Halperin Wernli\u535a\u58eb\u5bf9Creso\u7684\u627f\u8bfa\u3002 \u4ed6\u8bf4:\u201c\u5728\u5979\u4efb\u804c\u671f\u95f4\uff0c\u5979\u5728Creso Pharma\u7684\u6210\u529f\u4e2d\u53d1\u6325\u4e86\u5173\u952e\u4f5c\u7528\uff0c\u4e3a\u8463\u4e8b\u4f1a\u548c\u7ba1\u7406\u56e2\u961f\u5e26\u6765\u4e86\u5de8\u5927\u7684\u4ef7\u503c\uff0c\u5e76\u9886\u5bfc\u4e86\u4e00\u4e9b\u4e3e\u63aa\uff0c\u4e3a\u6211\u4eec\u7684\u80a1\u4e1c\u91ca\u653e\u4e86\u76f8\u5f53\u5927\u7684\u4ef7\u503c\u3002\u201d<\/p>\n","protected":false},"author":5,"featured_media":11137,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[721],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Creso\u5236\u836f\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"\u8fd1\u65e5\uff0cCreso Pharma (ASX: CPH)\u5ba3\u5e03\u4e86\u6536\u8d2d\u52a0\u62ff\u5927\u8ff7\u5e7b\u836f\u516c\u53f8Halucenex\u7684\u8ba1\u5212\uff0c\u5e76\u5ba3\u5e03\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8d1f\u8d23\u5176\u76ee\u6807\u516c\u53f8\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Creso\u5236\u836f\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"\u8fd1\u65e5\uff0cCreso Pharma (ASX: CPH)\u5ba3\u5e03\u4e86\u6536\u8d2d\u52a0\u62ff\u5927\u8ff7\u5e7b\u836f\u516c\u53f8Halucenex\u7684\u8ba1\u5212\uff0c\u5e76\u5ba3\u5e03\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8d1f\u8d23\u5176\u76ee\u6807\u516c\u53f8\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-17T03:24:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:51+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/03\/Creso-Pharma-ASX-CPH-Halucenex-Life-Sciences-True-North-Clinical-Research-PTSD-Post-Traumatic-Stress-Disorder-psilocybin.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Creso\u5236\u836f\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c\" \/>\n<meta name=\"twitter:description\" content=\"\u8fd1\u65e5\uff0cCreso Pharma (ASX: CPH)\u5ba3\u5e03\u4e86\u6536\u8d2d\u52a0\u62ff\u5927\u8ff7\u5e7b\u836f\u516c\u53f8Halucenex\u7684\u8ba1\u5212\uff0c\u5e76\u5ba3\u5e03\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8d1f\u8d23\u5176\u76ee\u6807\u516c\u53f8\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/03\/Creso-Pharma-ASX-CPH-Halucenex-Life-Sciences-True-North-Clinical-Research-PTSD-Post-Traumatic-Stress-Disorder-psilocybin.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/\",\"name\":\"Creso\u5236\u836f\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-03-17T03:24:59+00:00\",\"dateModified\":\"2023-08-29T18:01:51+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u8fd1\u65e5\uff0cCreso Pharma (ASX: CPH)\u5ba3\u5e03\u4e86\u6536\u8d2d\u52a0\u62ff\u5927\u8ff7\u5e7b\u836f\u516c\u53f8Halucenex\u7684\u8ba1\u5212\uff0c\u5e76\u5ba3\u5e03\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8d1f\u8d23\u5176\u76ee\u6807\u516c\u53f8\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Creso Pharma\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Creso\u5236\u836f\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c","description":"\u8fd1\u65e5\uff0cCreso Pharma (ASX: CPH)\u5ba3\u5e03\u4e86\u6536\u8d2d\u52a0\u62ff\u5927\u8ff7\u5e7b\u836f\u516c\u53f8Halucenex\u7684\u8ba1\u5212\uff0c\u5e76\u5ba3\u5e03\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8d1f\u8d23\u5176\u76ee\u6807\u516c\u53f8\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Creso\u5236\u836f\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c","og_description":"\u8fd1\u65e5\uff0cCreso Pharma (ASX: CPH)\u5ba3\u5e03\u4e86\u6536\u8d2d\u52a0\u62ff\u5927\u8ff7\u5e7b\u836f\u516c\u53f8Halucenex\u7684\u8ba1\u5212\uff0c\u5e76\u5ba3\u5e03\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8d1f\u8d23\u5176\u76ee\u6807\u516c\u53f8\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/","og_site_name":"smallcapsCN","article_published_time":"2021-03-17T03:24:59+00:00","article_modified_time":"2023-08-29T18:01:51+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/03\/Creso-Pharma-ASX-CPH-Halucenex-Life-Sciences-True-North-Clinical-Research-PTSD-Post-Traumatic-Stress-Disorder-psilocybin.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Creso\u5236\u836f\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c","twitter_description":"\u8fd1\u65e5\uff0cCreso Pharma (ASX: CPH)\u5ba3\u5e03\u4e86\u6536\u8d2d\u52a0\u62ff\u5927\u8ff7\u5e7b\u836f\u516c\u53f8Halucenex\u7684\u8ba1\u5212\uff0c\u5e76\u5ba3\u5e03\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8d1f\u8d23\u5176\u76ee\u6807\u516c\u53f8\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/03\/Creso-Pharma-ASX-CPH-Halucenex-Life-Sciences-True-North-Clinical-Research-PTSD-Post-Traumatic-Stress-Disorder-psilocybin.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/","url":"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/","name":"Creso\u5236\u836f\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-03-17T03:24:59+00:00","dateModified":"2023-08-29T18:01:51+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u8fd1\u65e5\uff0cCreso Pharma (ASX: CPH)\u5ba3\u5e03\u4e86\u6536\u8d2d\u52a0\u62ff\u5927\u8ff7\u5e7b\u836f\u516c\u53f8Halucenex\u7684\u8ba1\u5212\uff0c\u5e76\u5ba3\u5e03\u4efb\u547d\u4e00\u540d\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8d1f\u8d23\u5176\u76ee\u6807\u516c\u53f8\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Creso Pharma\u7684\u6536\u8d2d\u76ee\u6807Halucenex\u51c6\u5907\u8fdb\u884cPTSD\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2822"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2822"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2822\/revisions"}],"predecessor-version":[{"id":11136,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2822\/revisions\/11136"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/11137"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2822"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2822"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2822"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}